Organization · Accelerator
Koa Accel
Koa Accel is a medical device accelerator focused on supporting early-stage Class II medical device companies. Founded in 2019, it aims to reduce the high failure rate of medical device startups through enhanced business execution and development support.
Overview
What Koa Accel does
What Koa Accel is
Koa Accel is a medical device accelerator focused on supporting early-stage Class II medical device companies. Founded in 2019, it aims to reduce the high failure rate of medical device startups through enhanced business execution and development support.
How it participates in the startup ecosystem
The current public profile supports program host capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Accelerator
- Founded
- Founded in 2019
- Approximate age
- About 7 years
- Structured capabilities
- Program host
- Last reviewed
- March 28, 2026
What Accelerator means
An accelerator is a structured, short-term program designed to speed up a startup's progress toward product-market fit, traction, fundraising, or scale.
Open the glossary entryOfficial channels
Find Koa Accel elsewhere
Open the official website or a supported primary organization account.
Capability profile
Koa Accel as a program host
Program thesis
Koa Accel aims to transform innovative medical device ideas into successful commercial ventures by leveraging a team of experts in medical device development and strategic business execution.
Focus narrative
Koa Accel focuses on early-stage medical device startups, particularly those addressing significant unmet medical needs. The organization employs a proprietary evaluation process, the Koa Accel Scorecard™, to identify promising startups based on scientific and business criteria. Koa Accel provides initial funding to drive companies toward Series A funding within two years, compressing development timelines and reducing costs significantly.
Value and support
Koa Accel offers mentorship, initial funding, and access to a network of experts in medical device development and strategic business execution to help startups succeed.
Format and cadence
- Format
- In Person
Availability
- Application state
- Not published
Focus and fit
- Stages
- Accelerator · Pre-seed · Seed
- Sectors
- Healthcare · Medical Devices
- Regions
- United States
Alumni and track record
Alumni context
Koa Accel has invested in several notable companies, including: Makani Science: Developer of the Makani Respiration Monitor™, a device designed to monitor a patient's breathing during procedures involving conscious sedation. Microdermics: A medical device company focused on intradermal delivery systems using hollow microneedle technology for drug delivery and biosensing. Kahala Biosciences: Provides a COVID-19 testing solution that integrates antibody testing with blockchain technology through its ADIONA™ platform. Kino Discovery: A company that accelerates single-cell analysis using a patented microfluidic platform.
Common questions
What to know about Koa Accel
Upseed classifies Koa Accel under the Accelerator organization type. Its current public profile includes program host capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 28, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.